Fetal stem cell infusion aims to tame immune system attacks
NCT ID NCT03123458
First seen Nov 01, 2025 · Last updated Jun 14, 2026 · Updated 30 times
Summary
This early-stage study tests whether specially grown fetal stem cells can safely control severe symptoms of immune-related disorders and tissue damage. About 100 people with no other treatment options will receive an infusion of these cells. The main goal is to check for side effects and see if symptoms improve or stabilize.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE RELATED DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aerospace Center Hospital
Beijing, 100049, China
-
Capital Institute of Pediatrics affiliated Children's hospital
Beijing, Beijing Municipality, 100020, China
-
Shenzhen Geno-immune Medical Institute
Shenzhen, Guangdong, 518000, China
Conditions
Explore the condition pages connected to this study.